NCT00331682View on ClinicalTrials.gov

Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
Interventions
DRUG

alvocidib

Given IV

DRUG

docetaxel

Given IV

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00331682 - Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter